ClinicalTrialsFinder

Squamous Cell Carcinoma of the Skin Clinical Trials in Erlangen, Bavaria

1 recruitingErlangen, Bavaria, Germany

Showing 1–1 of 1 trials

Recruiting

Clinical Benefit and Biomarker Analysis of Combination of PD-1/PD-L1 Immune Checkpoint Inhibitors and Radiotherapy

Esophageal CancerUrothelial CarcinomaNSCLC+4 more
University of Erlangen-Nürnberg Medical School200 enrolled1 locationNCT04892849